Antiphospholipid syndrome is a distinct disorder with the clinical features of recurrent
thrombosis in the venous or arterial circulation and fetal losses. Its serological marker is the …

Recurrent pregnancy loss (RPL) affects 1% pregnancies and is multi‐factorial in origin. The
role of the acquired thrombophilia antiphospholipid syndrome (APS) as a common and …

A cardinal feature of systemic lupus erythematosus (SLE) is the development of
autoantibodies. The first autoantibodies described in patients with SLE were those specific …

Background: A clinical subtype of purely obstetrical antiphospholipid antibody (aPL‐Ab)
syndrome (APS) requires three or more unexplained consecutive embryonic losses before …

It is now widely accepted that antiphospholipid antibodies (aPL) have direct pathogenic
effects and that B cells, notably through aPL production, play a key role in the development …

Antiphospholipid syndrome (APS) is characterized by arterial and venous thrombosis,
pregnancy morbidity and fetal loss caused by pathogenic autoantibodies directed against …

Antiphospholipid antibodies (aPL) are a hallmark of the antiphospholipid syndrome (APS),
which is the most commonly acquired thrombophilia. To date there is consensus that aPL …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
persistent presence of antibodies directed against phospholipids and phospholipid-binding …

Monoclonal antibodies are used with great success in many different therapeutic domains.
In order to satisfy the growing demand and to lower the production cost of these molecules …

The antiphospholipid syndrome (APS) is characterised by thrombotic or obstetric symptoms
associated with persistent antiphospholipid antibodies (aPL). Despite an increasing …